IASO Bio Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 400

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 18

IASO Bio General Information

Description

Developer of cellular innovative drugs designed for cancer biotherapeutics. The company's cell-therapy products aim to treat symptoms of hematological tumors, solid tumors and virus associated tumors, enabling healthcare providers to prescribe more effective treatments to their patients.

Contact Information

Website
www.iasobio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Floor 8-10, Building D
  • Zhongdan Park, 3-1 Xinjinhu Road, Jiangbei New Area, Nanjing District
  • Nanjing, Jiangsu 210018
  • China
+86 025
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Floor 8-10, Building D
  • Zhongdan Park, 3-1 Xinjinhu Road, Jiangbei New Area, Nanjing District
  • Nanjing, Jiangsu 210018
  • China
+86 025

IASO Bio Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IASO Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 05-Jul-2024 Completed Clinical Trials - General
5. Later Stage VC (Series C1) 15-Jan-2023 Completed Clinical Trials - General
4. Later Stage VC 13-Nov-2022 Completed Clinical Trials - General
3. Later Stage VC (Series C) 16-Sep-2021 Completed Clinical Trials - General
2. Early Stage VC (Series B) 23-Mar-2020 $60M $69.5M Completed Clinical Trials - General
1. Early Stage VC (Series A) 28-Mar-2018 $9.5M $9.5M Completed Generating Revenue
To view IASO Bio’s complete valuation and funding history, request access »

IASO Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cellular innovative drugs designed for cancer biotherapeutics. The company's cell-therapy products aim to t
Drug Discovery
Nanjing, China
400 As of 2021

Cleveland, OH
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IASO Bio Competitors (44)

One of IASO Bio’s 44 competitors is Juventas Therapeutics, a Venture Capital-Backed company based in Cleveland, OH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Juventas Therapeutics Venture Capital-Backed Cleveland, OH
Genentech Formerly VC-backed South San Francisco, CA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Gadeta Formerly VC-backed Utrecht, Netherlands
Gracell Formerly VC-backed Shanghai, China
You’re viewing 5 of 44 competitors. Get the full list »

IASO Bio Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

IASO Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021118736-A Chimeric antigen receptor (car) binding to bcma, and applications thereof Active 01-Feb-2018

IASO Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IASO Bio Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovent Biologics Corporation Minority
Citic Securities Investment Growth/Expansion Minority
Efung Capital Venture Capital Minority
Hangzhou Hongcheng Capital Venture Capital Minority
HosenCare Brothers Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

IASO Bio FAQs

  • When was IASO Bio founded?

    IASO Bio was founded in 2017.

  • Where is IASO Bio headquartered?

    IASO Bio is headquartered in Nanjing, China.

  • What is the size of IASO Bio?

    IASO Bio has 400 total employees.

  • What industry is IASO Bio in?

    IASO Bio’s primary industry is Drug Discovery.

  • Is IASO Bio a private or public company?

    IASO Bio is a Private company.

  • What is IASO Bio’s current revenue?

    The current revenue for IASO Bio is .

  • How much funding has IASO Bio raised over time?

    IASO Bio has raised $250M.

  • Who are IASO Bio’s investors?

    Innovent Biologics, Citic Securities Investment, Efung Capital, Hangzhou Hongcheng Capital, and HosenCare Brothers are 5 of 18 investors who have invested in IASO Bio.

  • Who are IASO Bio’s competitors?

    Juventas Therapeutics, Genentech, Adaptimmune Therapeutics, Gadeta, and Gracell are some of the 44 competitors of IASO Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »